Bill Hooker is President of SourceOne Innovations, Inc., an executive coaching, procurement and supplier diversity consulting firm. His firm specializes in working with new and emerging businesses to significantly increase sales, develop high performing teams and enhance leadership skills.
After 30+ years of progressively advanced positions in the procurement, coaching and supplier diversity fields, Bill has developed a keen sense for what it takes to bring a supplier into an organization. Now as an independent consultant, he strives to help bring his clients actionable insight into what he refers to as the ‘secret sauce’ to bring those strategic partnerships to fruition.
During his time as a corporate member of several national diversity business organizations, Bill created a supplier diversity program for an international pharmaceutical company, and supported various outreach programs.
Bill holds an MBA, is a C.P.M., and an ICF (International Coach Federation) certified executive coach. Please visit his website for no obligation, complimentary services, or call (215) 595-7503.
Toby J.B. Patterson, MD
Toby Patterson, MD is Vice President of Immunology and Oncology, Medical Affairs, Abbvie, based in Chicago, IL, USA. In this capacity he functions as the physician executive leader to Immunology therapeutic area teams including: Biotherapeutics, Rheumatology, Dermatology, and Gastroenterology. Dr. Patterson did his medical training in South Australia, earning his Doctor of Medicine degree from The University of Adelaide. After graduation Dr. Patterson worked as a house officer in South Eastern Sydney Area Health Service.
Dr. Patterson moved to the US in 2009 where he worked for GE Healthcare on the development program and launch of targeted radiopharmaceutical diagnostics for neurodegenerative diseases. Dr. Patterson joined AbbVie in 2013 in the Neuroscience TA and has 11years medical and bio-pharmaceutical experience. Dr Patterson’s expertise is focussed on the practice of pharmaceutical medicine including new asset development, in market scientific support, Phase IIIb/IV research, launch excellence and brand success.
Dr. Michael Salgaller
Dr. Michael Salgaller leads the Invention Development and Marketing Unit within the National Institute of Health’s Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. Previously, he provided technical and strategic expertise to The Conafay Group, a DC-based government affairs firm – leading efforts on non-dilutive funding and alliance development. Previously, he was a key member of the business development team for the healthcare practice at SAIC, a Fortune-500 government contractor. He helped lead and deepen relationships with the Department of Health and Human Services – especially NIH and FDA – as well as foundations and patient advocacy groups. Before SAIC, he was a long-time industry executive who has held various positions in biotechnology and professional service firms including interim President of Biologics Consulting Firm, a boutique regulatory affairs consulting firm. In addition, Dr. Salgaller was on the investment team of Toucan Capital, a $120M early-stage venture firm dedicated to the life sciences, where he guided company formation and helped raise over $40M in follow-on financing. He began his career as a Senior Staff Scientist at the National Cancer Institute, where he oversaw a lab developing treatments for patients with terminal illnesses.
Dr. Salgaller serves on the Life Sciences Advisory Board of the Maryland Technology Council, and as a liaison to the Maryland-Israel Development Corporation and Maryland Technology Council. He is an advisor for DC ArchAngels and the Cooperative Angel Alumni Group. He is the author of “Biotechnology Entrepreneurship,” which is used as a reference text for courses at NIH and Catholic University, among others. He is an author of over 100 articles, presentations, and book chapters, and is on the editorial boards of several journals. For several years, he has served on the selection committee for Maryland’s Incubator Company of the Year Awards. Dr. Salgaller received his PhD in Pathology from The Ohio State University.
Veronica McCright joined Genentech in 2004 as the Head of U.S. Procurement Services. In this role she was responsible for Procurement Systems & Operations, Supplier Diversity and Procurement Data Management & Reporting. In April 2010, Veronica assumed the role of Head of U.S. Procurement with responsibility for supporting and leading the critical transition into a global Procurement organization during a time of significant change following the Roche acquisition. In October 2011, Veronica was responsible for managing the global G&A spend and related programs across Roche. With a global scope and teams in Switzerland and USA, Veronica spent two years based in Basel, Switzerland. In June 2016, Upon returning to South San Francisco, she assumed the new role of Head of North America Pharma. In this role Veronica is responsible for establishing the regional Procurement organization, setting the strategy and vision for Genentech Procurement and strengthening the Procurement footprint and value proposition across the business units.
Prior to joining Genentech, Veronica held managerial and leadership roles with increasing responsibility in the healthcare and financial industries. Veronica holds a Bachelors of Arts in Communications from California State University, Hayward, and a Master of Business Administration from the University of San Francisco. Veronica is based in South San Francisco.